Glenn Pierce
33Patents
12h-index
37Co-inventors
81Inventor score
Filing activity: Jun 28, 1994 → Feb 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5418222A | Multi-layered collagen film compositions for delivery of proteins and methods of using same | Human Necessities | 79 | Expired |
| US5858977A | Method of treating diabetes mellitus using KGF | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5824643A | Therapeutic uses of keratinocyte growth factor | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6613563B1 | Viral vectors with modified tropism | Chemistry; Metallurgy | 22 | Expired |
| US9050318B2 | Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US9233145B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 20 | Active |
| US5814605A | Therapeutic uses of keratinocyte growth factor | Emerging Cross-Sectional Technologies | 20 | Expired |
| US9675676B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 15 | Active |
| US9629903B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 14 | Active |
| US9670475B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 14 | Active |
| US9867873B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US9623091B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US9241978B2 | Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof | Emerging Cross-Sectional Technologies | 12 | Active |
| US7534774B2 | Traversal of nucleic acid molecules through a fluid space and expression in repair cells | Chemistry; Metallurgy | 12 | Expired |
| US5965530A | Therapeutic uses of keratinocyte growth factor | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6689351B1 | Use of GM-CSF to promote accelerated wound healing | Emerging Cross-Sectional Technologies | 8 | Expired |
| US10010622B2 | Factor VIII chimeric and hybrid polypeptides, and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10568943B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10548954B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11266720B2 | Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10221455B2 | Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy | Chemistry; Metallurgy | 3 | Active |
| US10881742B2 | Factor VIII chimeric and hybrid polypeptides, and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10898554B1 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11225650B2 | Methods of using FIX polypeptides | Chemistry; Metallurgy | 3 | Active |
| US10561714B2 | Factor IX polypeptides and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.